Literature DB >> 15736022

Incomplete antibody evolution and seroreversion after treatment of primary HIV type 1 infection: what is the clinical significance?

Elizabeth Connick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15736022     DOI： 10.1086/428131

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  3 in total

1.  Decreased Seroreactivity in Individuals Initiating Antiretroviral Therapy during Acute HIV Infection.

Authors:  Mark M Manak; Linda L Jagodzinski; Ashley Shutt; Jennifer A Malia; Mike Leos; Jason Ouellette; Siriwat Akapirat; Donn L Colby; Nittaya Phanuphak; Leigh Anne Eller; Merlin L Robb; Mark de Souza; Jintanat Ananworanich; Sheila A Peel
Journal:  J Clin Microbiol       Date:  2019-09-24       Impact factor: 5.948

2.  Altered Antibody Responses in Persons Infected with HIV-1 While Using Preexposure Prophylaxis.

Authors:  Ivana Parker; George Khalil; Amy Martin; Michael Martin; Suphak Vanichseni; Wanna Leelawiwat; Janet McNicholl; Andrew Hickey; J Gerardo García-Lerma; Kachit Choopanya; Kelly A Curtis
Journal:  AIDS Res Hum Retroviruses       Date:  2020-12-09       Impact factor: 2.205

3.  Absence of seroreversion in 80 HAART-treated HIV-1 seropositive patients with at least five-years undetectable plasma HIV-1 viral load.

Authors:  Marion Cornelissen; Suzanne Jurriaans; Jan M Prins; Margreet Bakker; Antoinette C van der Kuyl
Journal:  AIDS Res Ther       Date:  2006-02-16       Impact factor: 2.250
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.